Vertex Pharmaceuticals
VRTX
#158
Rank
A$167.11 B
Marketcap
$648.92
Share price
2.01%
Change (1 day)
8.26%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): A$0.40 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$10.62 Billion. In 2023 the company made an earning of A$7.08 Billion, an increase over its 2022 earnings that were of A$6.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.40 B-94.25%
2023 A$7.08 B3.19%
2022 A$6.86 B53.56%
2021 A$4.47 B-12.06%
2020 A$5.08 B118.45%
2019 A$2.32 B120.64%
2018 A$1.05 B1473.64%
2017 A$67.02 M197.6%
2016 A$22.52 M-102.97%
2015 -A$0.76 Billion-28.46%
2014 -A$1.07 Billion-51.5%
2013 -A$2.19 Billion-30584.68%
2012 A$7.17 M-95.47%
2011 A$0.15 B
2009 -A$0.95 Billion
2007 -A$0.67 Billion83.1%
2006 -A$0.37 Billion59.02%
2005 -A$0.23 Billion3.28%
2004 -A$0.22 Billion-38.16%
2003 -A$0.36 Billion
2000 -A$60.92 Million-20.38%
1999 -A$76.51 Million31.62%
1998 -A$58.13 Million91.05%
1997 -A$30.43 Million-36.24%
1996 -A$47.72 Million12.45%
1995 -A$42.44 Million27.4%
1994 -A$33.31 Million-1833.33%
1993 A$1.92 M-112.12%
1992 -A$15.86 Million175%
1991 -A$5.77 Million-12.2%
1990 -A$6.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.28 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.52 B 2,315.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.97 B 4,924.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$11.02 Billion-2,408.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.45 B 6,072.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.18 Billion-135.86%๐Ÿ‡บ๐Ÿ‡ธ USA